Screening of Bacteria Inhibiting <i>Clostridium perfringens</i> and Assessment of Their Beneficial Effects In Vitro and In Vivo with Whole Genome Sequencing Analysis
2022
Zipeng Jiang | Weifa Su | Mingzhi Yang | Wentao Li | Tao Gong | Yu Zhang | Chaoyue Wen | Xinxia Wang | Yizhen Wang | Mingliang Jin | Zeqing Lu
Various countries and organizations call for banning the use of antibiotic growth promoters (AGPs) as prophylaxis and for growth promotion in the livestock industry. Hence, seeking a substitute for antibiotics is strongly required by the livestock industry to maintain the productivity level and profits. Probiotics could represent one viable solution because of their beneficial effects on host health and maintaining the intestinal microbiota balance. In the present study, we aimed to isolate bacterial strains with probiotics properties from JinHua pig (a Chinese native pig breed) gastrointestinal tract that have antagonistic activity against to common disease-causing bacteria on farms. The four most potent strains were isolated (PP31, BA11, BA40, BV5) by the agar well diffusion method and further characterized by acid, bile salt, trypsin tolerance, whole genome sequencing (WGS), and suppressing <i>Clostridium perfringens</i> adhesion to IPEC-J2 cells. According to these results, BA40 had the highest number and variety of probiotic secondary metabolic secretion genes and capacity to exclude the attachment of <i>Clostridium perfringens</i> to IPEC-J2 cells as same as PB6. The animal experiment in vivo illustrated that BA40 and PB6 could reduce the phenomenon induced by <i>Clostridium perfringens</i> challenge of body weight loss, colon length decrease, pro-inflammatory cytokine increase, and <i>Clostridium perfringens</i> and <i>Escherichia coli</i> increase. The present study provides evidence that BA40 could represent a novel probiotic candidate as PB6, which exhibited some probiotic features and mitigated the burden of <i>Clostridium perfringens</i> associated gut disease.
显示更多 [+] 显示较少 [-]